Pacanalotamab is a bispecific T-cell engager (BiTE®) antibody construct targeting B cell maturation antigen (BCMA) and CD3ε. By bridging T cells and BCMA-expressing multiple myeloma cells, Pacanalotamab promotes potent T cell–mediated cytotoxicity. It is a valuable tool for preclinical evaluation of immune cell redirection and targeted therapies in hematologic malignancies.
Pacanalotamab is a bispecific T-cell engager (BiTE®) antibody construct targeting B cell maturation antigen (BCMA) and CD3ε. By bridging T cells and BCMA-expressing multiple myeloma cells, Pacanalotamab promotes potent T cell–mediated cytotoxicity. It is a valuable tool for preclinical evaluation of immune cell redirection and targeted therapies in hematologic malignancies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
